US Zamto-cel Autoimmune Diseases

Abroad (travel likely)RecruitingPHASE1

Conditions

Lupus Nephritis · Systemic Lupus Erythematosus · Systemic Sclerosis (SSc) · Diffuse Cutaneous Systemic Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Contact: Study coordinator (Kiley Timler) · ktimler@mcw.edu

Study leads

Esther Eromosele, MD
Study Director
Miltenyi Biomedicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Autoimmune Disorders · Systemic Sclerosis · Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE1, PHASE2

Houston, United States · Houston, United States

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Systemic Lupus Erythematosus (With and Without Nephritis) · Idiopathic Inflammatory Myopathy · Systemic Sclerosis

Abroad (travel likely)RecruitingPHASE1

Phoenix, United States · Loma Linda, United States

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Systemic Lupus Erythematosus (SLE) · Lupus Nephritis (LN) · Systemic Sclerosis (SSc)

Abroad (travel likely)RecruitingPHASE1

Hefei, China

SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus

REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS · Lupus Nephritis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Shenzhen, China